Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Advocacy at a Glance 4/23/21 Advocacy at a Glance 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Advocacy at a Glance 2/19/21 Advocacy at a Glance 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More Newer Posts Older Posts
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Advocacy at a Glance 4/23/21 Advocacy at a Glance 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More
Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Advocacy at a Glance 2/19/21 Advocacy at a Glance 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More
Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More
